RAPID METHODS FOR DETERMINING MICROORGANISM GROWTH IN SAMPLES OF HUMAN ORIGIN

Continuous monitoring of blood cultures using pH- (or CO2-) based detection platforms is the current clinical gold standard. Despite the ubiquity of these systems in state-of-the-art clinical microbiology laboratories, they offer slow times-to-result (TTR) because microorganism detection typically r...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	VACIC, Aleksandar, ERSEN, Ali, BRISCOE, Matthew, FLENTIE, Kelly, BAKER, Kristin, STERN, Eric, SPEARS, Benjamin R
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Continuous monitoring of blood cultures using pH- (or CO2-) based detection platforms is the current clinical gold standard. Despite the ubiquity of these systems in state-of-the-art clinical microbiology laboratories, they offer slow times-to-result (TTR) because microorganism detection typically requires >109 colony forming units (CFU) to be present whereas only 1-1000 CFU are typically present in septic patient blood samples. These TTRs are further lengthened for samples collected from spoke sites in consolidated hub-and-spoke laboratory models, an increasingly common model for integrated hospital networks and reference laboratories, because sample transport time, typically >4 hours, is lost. Here we introduce new methods that allow microorganisms to be detected at